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We have demonstrated that ribosomal protein S19 (RP S19) polymer, when crosslinked between Lys122
and Gln137 by activated coagulation factor XIII, acts as a C5a receptor (C5aR) antagonist/agonist. Based
on experimental data obtained using RP S19 analog peptide and recombinant protein monomer, we
suggested that L131DR, I134AGQVAAAN and K143KH moieties in the RP S19 C‐terminus act in, respectively,
C5aR binding, penetration of the plasma membrane, and interaction with either an apoptosis-inducing
molecule in neutrophils (delta lactoferrin) or a calcium channel-activating molecule (annexin A3) to
induce the p38 MAPK pathway in macrophages. Recently, we observed RP S19 trimer in serum. To study
the effects of this RP S19 trimer on C5aR, we prepared mutant RP S19 C‐terminal peptide (RP S19122-145)
dimer and trimer, and examined their chemotactic activities and signal transduction pathways in human
C5aR-overexpressing squamous cell carcinoma HSC-1 (HSC-1C5aR) cells using 24 trans-well chamber and
western blotting assays, respectively. HSC-1C5aR cells were attracted by RP S19122-145 dimer and vice versa
by RP S19122-145 trimer. The RP S19122-145 dimer-induced attraction was competitively blocked by pre-
treatment with RP S19122-145 trimer. Moreover, RP S19122-145 trimer-induced p38 MAPK phosphorylation
was stronger than RP S19122-145 dimer-induced p38 MAPK phosphorylation. RP S19122-145 trimer ap-
peared to act as a C5aR antagonist. The agonistic and antagonistic effects of RP S19122-145 dimers and
trimers were reﬂected by monocytic, THP-1-derived macrophage-like cells. Unlike the C5aR agonist C5a,
which acts at the inﬂammation phase of acute inﬂammation, RP S19 trimer might act as a C5aR an-
tagonist at the resolution phase.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
C5a is generally cleaved from C5 (a plasma protein released from
hepatocytes) by C5 convertase at the inﬂammatory phase of acute
inﬂammation [1]. The chemotactic potency of neutrophils is usually
suppressed in C5-deﬁcient acute inﬂammation mouse models [2].
Therefore, we believe that C5a functions as a neutrophil C5a re-
ceptor (C5aR) agonist to transmit a pro-inﬂammatory signal. Based
on the NMR structure of C5a and experiments in which C5aR is
mutated, the C5a C-terminus (L72GR) has been suggested to bind to
C5aR-activating sites [3,4]. When the GDP form of the Gαi2 subunitB.V. This is an open access article u
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ed.ac.jp (K. Yamanegi).is exchanged with the GTP form of this subunit via the guanidine
exchange factor activity of C5aR, the Gβγ subunits commonly in-
teract with phospholipase Cβ2 in an intracellular calcium-depen-
dent manner. After intracellular calcium is released, the calcium
channel on the plasma membrane is activated (opened), thereby
inducing cell motility through the signals of phosphatidylinositol
3-kinase and the extracellular signal-regulated protein kinases 1/2
(ERK1/2). The C5aR C-terminal phosphorylation that is downstream
of the ERK1/2 pathway induces receptor internalization to restrict
excessive neutrophil action. The C5aR gene is known not to have
splice variant mRNAs [5]. However, excessive neutrophil activation
is sometimes observed during the resolution phase in C5aR-deﬁ-
cient acute inﬂammation mouse models [6,7].
We puriﬁed S19 ribosomal protein (RP S19) polymer as a
monocyte-speciﬁc chemoattractant in rheumatoid arthritis syno-
vial tissue extracts [8]. In this case, RP S19 monomers in apoptotic
cells are crosslinked between Lys122 and Gln137 due to the acti-
vation of tissue transglutaminases. Conversely, RP S19 monomers
in plasma move to phosphatidylserine on platelets during acute
inﬂammation and are crosslinked due to the activation of coagu-
lation factor XIII [9]. Based on data obtained using mutatednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tracted monocytes/macrophages but not neutrophils [10]. More-
over, L131DR and I134AGQVAAANKKH moieties located in the RP
S19 C‐terminus functioned in C5aR binding and in antagonistic or
agonistic switching, respectively. To examine the cell type-speciﬁc
switching mechanism, we prepared the Gly73Asn mutant of C5a
recombinant protein containing I134AGQVAAANKKH, C5a/RP S19.
Interestingly, partner molecules to C5a/RP S19 include delta lac-
toferrin (δLf) in neutrophils and full-length annexin A3 (ANXA3)
in macrophages [11,12]. δLf is a transcription factor that induces
apoptosis. Conversely, ANXA3 is an activator that opens calcium
channels on the plasma membrane to transmit signals in the p38
mitogen-activated protein kinase (p38 MAPK) pathway. Therefore,
we suggested that the RP S19 polymer functions as a cell-speciﬁc
C5aR antagonist/agonist.
The RP S19 monomer in plasma and the corresponding polymer
in serumwere detected using anti-RP S19 rabbit IgGs [13]. Especially,
RP S19 polymer was cross-reacted with anti-C5a rabbit IgGs. We
recently observed a band at 50 kDa that reacted with both anti-RP
S19 and anti-C5a rabbit IgGs using western blotting, as previously
shown in guinea pig serum [14,15]. To study the roles of the RP S19
trimer in serum, we newly prepared the mutant RP S19122-145 peptide
(RP S19122-145) trimer and C5aR-overexpressing human squamous cell
carcinoma HSC-1 (HSC-1C5aR) cells. The RP S19122-145 trimer appeared
to work as a C5aR antagonist through inducing a strong p38 MAPK
signal. The RP S19 trimer most likely acts as a C5aR antagonist during
the resolution phase of acute inﬂammation.2. Materials and methods
2.1. Reagents
The RP S19 C‐terminus (K122LTPQGQRDLDRIAGQVAAANKKH)
peptide (the RP S19122-145 monomer) was prepared using Fmoc-solid(C) RP S19122-145 dimer
KLPQGQRDLDRIAGQVAAANKKH
KLPQGQRDLDRIAGQVAAANK
HN
O
N
N
N
(A) RP S19122-145 monomer
KLPQGQRDLDRIAGQVAAANKKH
(D) RP S19122-145 trimer
KLPQGQRDLDRIAGQVAAANKK
KLPQGQRD
HN
O O
S
NH
HN
O
Fig. 1. Activation of HSC-1C5aR cells by the RP S19122-145 monomer. (A, C, D) Schematic
skeleton is replaced with a triazole or thioether skeleton for synthetic reasons. (B) A re
image was obtained using ﬂuorescence microscopy 10 min after the stimulation (100phase synthesis and an automated peptide synthesizer (Liberty Blue;
CEM Corporation, NC, USA); Fmoc-NH-SAL resin was used to prepare
the C-terminal amide, and H-His(Trt)-Trt(2-Cl) resin was used to
prepare the C-terminal acid (Watanabe Chemical Ind., Hiroshima,
Japan) (Fig. 1A). The peptides were puriﬁed using reversed-phase
high performance liquid chromatography (HPLC) and C18 columns
(Nacalai tesque, Kyoto, Japan); the identity of the peptides was con-
ﬁrmed by mass spectrometry using Autoﬂex (Bruker Daltonics, MA,
USA) or LCQDeca XP Plus (Thermo Scientiﬁc, MA, USA) instruments
and quantitative amino acid analysis. The RP S19122-145 dimer (linked
by triazole) was prepared using Click chemistry (Fig. 1C) [16]. Thus,
the RP S19122-145 trimer was linked by thioether and triazole bonds
(Fig. 1D).
Ac-RP S19122-145-Asp-Gly-Gly-Cys-NH2 was ﬂuorescence-labeled at
the C-terminal Cys residue as a thioether by reaction with Alexa
Fluor 568 C5 (Invitrogen, CA, USA) (RP S19122-145-Cysalkyl-Cy5
monomer) (Fig. 2A) or as a disulﬁde by reaction with a reagent
that was prepared by reacting Alexa Fluor 568 C5, NHS ester and
2-aminoethyl methanethiosulfonate (RP S19122-145-CysSS-Cy5
monomer) (Fig. 2B).
2.2. Vector and HSC-1 cells
To generate HSC-1 transformed cells, pCMV6-C5aR1-GFP cDNA
(NM_001736) (OriGene Technology, Inc. MD, USA) was cleaved
using EcoRI restriction enzyme (TAKARA, Kyoto, Japan) and
transferred into HSC-1 cells (RIKEN BioResource Center, Tukuba,
Japan) using a NAPA21 electroplater (Nepa Gene Co., Ltd. Chiba,
Japan) according to a protocol that was approved by the Research
Ethics Committee of the Japanese Hyogo College of Medicine (No.
1793) in accordance with the Helsinki Declaration of 1975, as re-
vised in 2002. Successfully transformed cells (HSC-1C5aR cells)
were sorted using a BD FACSAria™III Cell Sorter (BD bioscience,
Tokyo, Japan). The optimal clone was selected based on growth
rate and sensitivity to the RP S19122-145 monomer. MorphologicalKH
H
LDRIAGQVAAANKKH
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models of the RP S19122-145 monomer, dimer and trimer, in which the isopeptide
presentative morphological change of HSC-1C5aR cells is shown (white arrow); the
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Fig. 2. Localization of the RP S19122-145 monomer C-terminus in HSC-1C5aR cells. The positions of the RP S19122-145-Cysalkyl-Cy5 monomer (A) and the RP S19122-145-CysSS-Cy5
monomer (B) were observed by laser scanning microscopy in HSC-1C5aR cells at 5 min and 30 min after the stimulation (n¼6). Representative positions of C5aR and the
peptide C-terminus are shown as green or red dots in the lower left or right 30-min images. Yellow dots in the fused images are only shown in the upper right 30 min image.
H. Nishiura et al. / Biochemistry and Biophysics Reports 7 (2016) 70–7672changes of HSC-1C5aR cells were usually observed using a Ti-E
immunoﬂuorescence microscope (Nikon, Tokyo, Japan). For ana-
lyses of Cy5 localization, HSC-1C5aR cells were observed using an
Axiovert/LSM510 instrument (Carl Zeiss, North Ryde, Australia).
2.3. Chemotaxis assay
HSC-1C5aR cells (4105 cells/mL) were prepared in DMEM
medium containing 10% FBS and 100 U penicillin/streptomycin for
a chemotaxis assay in a 24-well trans-well chamber [17]. 1105
indicator cells in 250 mL and 106 M chemoattractants in 1 mL of
the same cell culture medium were applied to the upper chamber
equipped with an 8-mm pore ﬁlter and the lower chamber,
respectively.
First, 1105 monocytic THP-1 cells (RIKEN BioResource Center,
Tsukuba, Japan) in 250 mL of the cell culture medium containing
100 nM phorbol 12-myristate 13-acetate (PMA) (the cell differ-
entiation medium) and 1 mL of the same differentiation medium
were applied to the upper and lower chambers, respectively. After
one day, the cell differentiation medium in the lower or upper
chambers was changed to the cell culture mediumwith or without
106 M of chemoattractants.
After 6 h of culture in an incubator under 5% CO2 at 37 °C with
85% humidity, the number of cells that migrated from the upper
chamber to the lower chamber was counted using the trypan-blue
dye exclusion method; at least 3 wells were counted in each of
4 different experiments.
2.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and
Western blotting
Total proteins of HSC-1C5aR cells were suspended in lysis buffer
(7 M urea, 2 M thiourea, 1% Triton X-100, 18 mM dithiothreitol, and
0.1% bromothymol blue) and applied to 12% SDS-polyacrylamide
gel electrophoresis gels. The proteins were electrophoretically
transferred to an Immobilon Transfer Membrane™ (Millipore, MA,USA) using a semi-dry electroblotter (Sartorius, Göttingen, BRD)
for 90 min using a current of 15 V. Phosphorylated and nonpho-
sphorylated anti-p38 MAPK or anti-ERK1/2 rabbit IgGs were ob-
tained from Cell Signaling Technology (MA, USA). Primary anti-
bodies (200 ng/mL) were incubated for 1 h at 22 °C, and HRP-
conjugated anti-rabbit IgGs goat IgGs secondary antibody
(20 ng/mL; Santa Cruz Biotechnology, CA, USA) was incubated for
30 min at 22 °C. The signals were detected using the ECL-Plus
Western Blotting Detection System™ (GE Healthcare, Tokyo, Ja-
pan). The phosphorylation ratio of p38 MAPK to ERK1/2 was cal-
culated based on the non-phosphorylated band densities in Wes-
tern blots using ImageJ 1.46 (National Institutes of Health, MD,
USA).
2.5. Statistical analysis
Each result was conﬁrmed in multiple experiments using a
minimum of three samples. Statistical signiﬁcance was calculated
by non-parametric and parametric tests with two-way analysis of
variance. The values are presented as the means7SD. A P-
valueo0.05 was considered statistically signiﬁcant, and the re-
sults are presented as Po0.05 (*) or Po0.01 (**).3. Results and discussion
3.1. The roles of the RP S19 C‐terminus in C5aR
RP S19 recombinant protein monomers were crosslinked due to
the activation of coagulation factor XIII, and at least 4 kinds of
fractions were collected by HPLC using a C4 column. The main
components in fractions 1–4 were identiﬁed using sodium dodecyl
sulfate polyacrylamide gel electrophoresis as the intra-crosslinked
monomer and the inter-crosslinked dimer, tetramer and hexamer,
respectively [18]. The purity of each fraction was at least 50%. The
chemotactic activity against monocytes/macrophages was slightly
Fig. 3. Interaction of the RP S19122-145 monomer with C5aR in HSC-1C5aR cells. HSC-1C5aR cells in the upper chamber were stimulated with vehicle buffer, RP
S19122-145-Cysalkyl-Cy5 monomer or RP S19122-145-CysSS-Cy5 monomer in a trans-well chamber assay (n¼4).
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fractions. Moreover, the antagonistic/agonistic dual functions of
the RP S19 polymer were reﬂected by both C5a/RP S19 re-
combinant protein and analog peptide monomers. We recently
showed that RP S19 C‐terminus includes three regions: the C5aR
binding region (L131DR), the membrane-penetrating region
(I134AGQVAAAN), and the antagonist/agonist switching region
(K143KH) [19,20]. Therefore, we suggested that the RP S19122-145
trimer acts as a C5aR antagonist/agonist.
3.2. LDR-mediated polarization activity of the RP S19122-145 mono-
mer in HSC-1C5aR cells
To observe the polarization activity of the RP S19122-145
monomer in HSC-1C5aR cells, 1104 cells were seeded on a
Φ30 mm glass-bottomed cell culture dish (Fig. 1A). After one day,
106 M RP S19122-145 monomer was mixed with the culture
medium, and the resulting morphological change of the HSC-1C5aR
cells was observed. Spike-like ﬁlopodia were clearly visible after
10 min (Fig. 1B white arrows). These data suggest that the K143KH
moiety in the RP S19122-145 monomer interacted with ANXA3 in
HSC-1C5aR cells to induce the p38 MAPK pathway.
3.3. IAGQVAAAN-mediated localization of the RP S19122-145 mono-
mer in HSC-1C5aR cells
To conﬁrm the membrane-penetrating activity of the RP
S19122-145 monomer, 1105 HSC-1C5aR cells were seeded on a
Φ30 mm glass-bottomed cell culture dish. After one day, 106 M
RP S19122-145-Cysalkyl-Cy5 monomer (Fig. 2(A)) or RP
S19122-145-CysSS-Cy5 monomer (Fig. 2B) was mixed with the culture
medium, and the localization of the monomer in HSC-1C5aR cells
was observed. At 5 min after stimulation, the RP
S19122-145-Cysalkyl-Cy5 monomer C-terminus was mainly observed
on the cytoplasmic side of the plasma membrane. This localization
did not change until at least 30 min after stimulation. These data
reﬂected a lack of C5aR internalization after the stimulation with
C5a/RP S19 through the p38 MAPK pathway [21]. At 5 min after
stimulation, the RP S19122-145-CysSS-Cy5 monomer C-terminus was
also mainly observed at the cytoplasmic side of the plasma
membrane. However, the RP S19122-145-CysSS-Cy5 monomer C-ter-
minus moved to the cytoplasmic side at 30 min after the stimu-
lation. Thus, -S-Cy5 in RP S19122-145-CysSS-Cy5 monomer wasprobably cleaved in the cytoplasm. We did not observe any mor-
phological changes of the HSC-1C5aR cells in this experimental
setting. The C-terminal modiﬁcations most likely affected the in-
teraction of the K143KH moiety with ANXA3. These data conﬁrmed
the roles of I134AGQVAAAN in membrane penetration, in addition
to C5aR.
3.4. The KKH-mediated chemotactic activity of RP S19122-145 mono-
mer on HSC-1C5aR cells
To conﬁrm the effect of the C-terminal modiﬁcation of the RP
S19122-145 monomer on the K143KH-ANXA3 complex-mediated
chemotactic signal, HSC-1C5aR cells were stimulated with the RP
S19122-145-Cysalkyl-Cy5 monomer or the RP S19122-145-CysSS-Cy5
monomer in a trans-well chamber (Fig. 3). At 6 h after the sti-
mulation, HSC-1C5aR cells in the upper chamber signiﬁcantly mi-
grated into the lower chamber containing the RP
S19122-145-Cysalkyl-Cy5 monomer or the RP S19122-145-CysSS-Cy5
monomer to a greater extent than HSC-1 cells. These data in-
dicated that the -Cysalkyl-Cy5 modiﬁcation but not the -CysSS-
Cy5 modiﬁcation to the K143KH moiety of the RP S19122-145
monomer affected the complex with ANXA3 to induce chemotaxis
through the p38 MAPK pathway.
3.5. The roles of the RP S19122-145 trimer in C5aR
To examine the roles of the RP S19122-145 trimer in C5aR, HSC-1
cells or HSC-1C5aR cells were stimulated with the monomer, the
dimer or the trimer (see Fig. 1A, C, and D) in a trans-well chamber
(Fig. 4A). At 6 h after the stimulation, the number of HSC-1 cells
that migrated into the chamber containing any RP S19 peptides
was signiﬁcantly lower than the number of HSC-1C5aR cells that
migrated. When using vehicle buffer, no signiﬁcant difference was
observed. C5aR was speciﬁcally activated by RP S19122-145 pep-
tides. Interestingly, the chemotactic activity of the RP S19122-145
dimer or trimer was the highest or lowest among the RP S19122-145
peptides. The chemotactic activity of the RP S19122-145 trimer was
signiﬁcantly higher than that of vehicle buffer.
To conﬁrm the structure of the RP S19122-145 trimer, 1105
HSC-1C5aR cells were mixed with 106 M RP S19122-145 trimer or
vehicle buffer for 5 min These mixtures and 106 M RP S19122-145
dimer or trimer were applied to the upper and lower chambers,
respectively (Fig. 4B). After 6 h of incubation, the number of
Fig. 4. RP S19122-145 dimer and trimer acted oppositely on C5aR in HSC-1C5aR cells. (A) HSC-1 cells or HSC-1C5aR cells in the upper chamber were stimulated with vehicle
buffer, RP S19122-145 monomer, RP S19122-145 dimer or RP S19122-145 trimer in a trans-well chamber assay (n¼4). (B) HSC-1C5aR cells were pre-mixed with or without RP
S19122-145 trimer for 10 min, and indicator cells in the upper chamber were stimulated with RP S19122-145 dimer or RP S19122-145 trimer in a trans-well chamber assay (n¼4).
(C) HSC-1C5aR cells in Φ 100 mm cell culture dish were stimulated with vehicle buffer, RP S19122-145 monomer, RP S19122-145 dimer or RP S19122-145 trimer (n¼4). Phos-
phorylated and non-phosphorylated p38MAPK and ERK1/2 proteins were detected using Western blotting. (D) The phosphorylation ratio of p38 MAPK to ERK1/2 was
calculated based on the non-phosphorylated band densities in Western blots using ImageJ 1.46.
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S19122-145 dimer was signiﬁcantly decreased when pre-treated
with the RP S19122-145 trimer.
To study the sensitivity of the RP S19122-145 trimer to the C5aR-
mediated p38 MAPK signal in HSC-1C5aR cells, 1106 cells were
seeded on a Φ100 mm cell culture dish (Fig. 4C). After one day,
106 M of the monomer, dimer or trimer were mixed with culture
medium for 20 min, and proteins in the attached cells were col-
lected for Western blotting. p38 MAPK phosphorylation was
highest and lowest in HSC-1C5aR cells after stimulation with the RP
S19122-145 trimer and vehicle buffer. Conversely, ERK1/2 phos-
phorylation was highest and lowest in HSC-1C5aR cells after sti-
mulation with vehicle buffer and the RP S19122-145 trimer. ERK1/2
phosphorylation was most likely detected via constitutively acti-
vated GPCRs. The p38 MAPK/ERK1/2 phosphorylation ratio ap-
peared to change from antagonist to agonist (Fig. 4D). The RP
S19122-145 trimer commonly acts as a C5aR antagonist via a strong
p38 MAPK signal in HSC-1C5aR cells.
To explain the high p38 MAPK/ERK1/2 phosphorylation ratio in
HSCC5aR cells in response to RP S19122-145 trimer in our experi-
mental setting, we suggest that the following sequence of events
occurs after the RP S19122-145 trimer interacts with one C5aR (see
Graphical Abstract): (1) any L131DR moieties in the three RP S19
peptides can bind to the active pocket near the top of the 5th
transmembrane of C5aR. (2) One G protein transmits one ERK1/2
signal via the active form of one C5aR. (3) All I133AGQVAAAN
moieties in the three RP S19 peptides penetrate the plasma
membrane. (4) All K143KH moieties move to the cytoplasmic side
of the plasma membrane. We did not examine the afﬁnities of the
K143KH moiety to ANXA3 and δLf. (5) RP S19122-145 monomer: one
p38 MAPK signal is transmitted via one K143KH moiety through
one ANXA3. The weak chemotaxis activity is induced via one
C5aR-mediated ERK1/2 signal plus one p38 MAPK signal. (6) RP
S19122-145 dimer: one p38 MAPK signal is transmitted via one
K143KH moiety through one ANXA3. One RGS3 increases GTPase
activity of the Gα subset via another K143KH moiety through oneδLf, which results in the association of the Gα and Gβγ subsets.
The association of G protein decreases the C5aR-mediated ERK1/2
signal. The strong chemotaxis activity is induced via one C5aR-
mediated half ERK1/2 signal plus one p38 MAPK signal. (7) RP
S19122-145 trimer: two p38 MAPK signals are transmitted via two
K143KH moieties through two ANXA3s. The C5aR-mediated ERK1/2
signal is decreased by one RGS3. No chemotactic activity is in-
duced via one C5aR-mediated half ERK1/2 signal plus two p38
MAPK signals. Currently, we are interested in studying several
types of RP S19122-145 trimer interactions with C5aRs on two or
three cells of the same type and with C5aRs on two or three cells
of different types.
Interestingly, several reports indicate that the migration of
glioma cells in response to lysophosphatidic acid is partially in-
hibited by the activation of the p38 MAPK pathway in response to
the down-regulation of cdc-42 [22]. Conversely, the p38 MAPK-
enhanced invasion of colon cancer Caco-2 and HT29cells is in-
hibited in response to the down-regulation of MMP-9 [23]. Also
interestingly, reports indicate that the p38 MAPK signal appears to
promote apoptosis in bladder carcinoma cells or cancer stem cells,
as previously shown by us in apoptotic cells, including neutrophils
[24,25].
3.6. The roles of the GPCR agonist trimer
Based on solution NMR and x-ray crystallography data, CXC and
CC chemokines are believed to work mainly during the in-
ﬂammatory phase of acute inﬂammation as a monomer. However,
N-terminal cysteines are believed to have strong dimerization
potential [26]. Experimentally, dimerization is sensitive to solution
conditions, such as low pH and long ionic strength. When CCL2
and CCL4 were experimentally linked by disulﬁde bonds, the di-
mer did not bind to their receptors. Conversely, the CXCL8 dimer
bound to another receptor, CXCR2 [27,28]. We recommend that all
chemokine researchers attempt to purify chemokine polymers in
biomaterials. We strongly suggest that a crosslinked chemokine
Fig. 5. RP S19122-145 dimer and trimer acted oppositely on the C5aR in macrophage-like THP-1 cells. (A) THP-1 cells or the macrophage-like THP-1 cells in the upper chamber
were stimulated with vehicle buffer, RP S19122-145 monomer, RP S19122-145 dimer or RP S19122-145 trimer in a trans-well chamber assay (n¼4). (B) The macrophage-like THP-1
cells were pre-mixed with or without RP S19122-145 trimer for 10 min, and indicator cells in the upper chamber were stimulated with RP S19122-145 dimer or RP S19122-145
trimer in a trans-well chamber assay (n¼4).
H. Nishiura et al. / Biochemistry and Biophysics Reports 7 (2016) 70–76 75that is polymerized by factor XIIIa is present in serum.
As shown in Fig. 5, we conﬁrmed the agonistic and antagonistic
dual effects on macrophage-like THP-1 cells. THP-1 cells do not
generally express δLf, which means that three p38 MAPK signals
are transmitted via three K143KH moieties through three ANXA3s
(see Graphical Abstract). The strong p38 MAPK signals might
connect directly to unknown antagonistic pathways.
Conversely, chemokine polymer research also suggests that
these CXC and CC chemokines play a role in cancer metastasis.
When CXCL12 monomer binds to CXCR4, Gs protein-dependent
inhibition of cAMP signaling promotes metastasis [29]. In the case
of the CXCL12 dimer, CXCR4 also promotes metastasis through
another signal transduction pathway via the weak phosphoryla-
tion of ERK1/2. In addition, ligand-independent polymerization
endows CXCR4 with an enhanced afﬁnity for CXCL12 [30]. We
need to further examine the roles of ligand-dependent
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